Nephromics (U.S. royalty obligation and worldwide diagnostics assets)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
U.S. royalty obligation and rights of worldwide diagnostics assets of Nephromics. The license is for tests related to the detection, monitoring and risk assessment of preeclampsia, a leading cause of maternal death.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Business Products and Services
Acquirer
Primary Office
- Chestnut Hill, MA
- United States
Nephromics (U.S. royalty obligation and worldwide diagnostics assets) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Nephromics (U.S. royalty obligation and worldwide diagnostics assets)‘s full profile, request access.
Request full access to PitchBookNephromics (U.S. royalty obligation and worldwide diagnostics assets) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Nephromics (U.S. royalty obligation and worldwide diagnostics assets)‘s full profile, request access.
Request full access to PitchBook